Taiwan · Delayed Price · Currency is TWD Yoda Pharmaceuticals Statistics
Total Valuation
TPEX:7829 has a market cap or net worth of TWD 3.81 billion. The enterprise value is 2.73 billion.
| Market Cap | 3.81B |
| Enterprise Value | 2.73B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7829 has 99.39 million shares outstanding. The number of shares has increased by 22.93% in one year.
| Current Share Class | 99.39M |
| Shares Outstanding | 99.39M |
| Shares Change (YoY) | +22.93% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 21.98% |
| Owned by Institutions (%) | 11.60% |
| Float | 43.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 32.84, with a Debt / Equity ratio of 0.00.
| Current Ratio | 32.84 |
| Quick Ratio | 32.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -23,977.06 |
Financial Efficiency
Return on equity (ROE) is -48.22% and return on invested capital (ROIC) is -31.72%.
| Return on Equity (ROE) | -48.22% |
| Return on Assets (ROA) | -30.44% |
| Return on Invested Capital (ROIC) | -31.72% |
| Return on Capital Employed (ROCE) | -35.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:7829 has paid 1.10 million in taxes.
| Income Tax | 1.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +19.79% |
| 50-Day Moving Average | 40.57 |
| 200-Day Moving Average | 50.31 |
| Relative Strength Index (RSI) | 66.20 |
| Average Volume (20 Days) | 33,399 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -383.63M |
| Pretax Income | -362.96M |
| Net Income | -364.07M |
| EBITDA | -381.91M |
| EBIT | -383.63M |
| Earnings Per Share (EPS) | -4.08 |
Balance Sheet
The company has 1.08 billion in cash and 408,000 in debt, with a net cash position of 1.08 billion or 10.85 per share.
| Cash & Cash Equivalents | 1.08B |
| Total Debt | 408,000 |
| Net Cash | 1.08B |
| Net Cash Per Share | 10.85 |
| Equity (Book Value) | 1.07B |
| Book Value Per Share | 10.73 |
| Working Capital | 1.05B |
Cash Flow
In the last 12 months, operating cash flow was -315.45 million and capital expenditures -518,000, giving a free cash flow of -315.97 million.
| Operating Cash Flow | -315.45M |
| Capital Expenditures | -518,000 |
| Depreciation & Amortization | 1.72M |
| Net Borrowing | -802,000 |
| Free Cash Flow | -315.97M |
| FCF Per Share | -3.18 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7829 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.93% |
| Shareholder Yield | -22.93% |
| Earnings Yield | -9.56% |
| FCF Yield | -8.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |